Bioanalytical Systems, Inc. (BASI): Why Has Large Pharma Not Snapped This Up?
5 Steps to a Successful Cannabis Dispensary Opening...
How Does the Snapchat IPO Stack up to Facebook and Twitter?
Maximizing Your Roth IRA in Two Steps
Why California's Pain Could Be the US Economy's Gain
Dr. Daniel Teper, CEO of Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) sits down with Equities.com's Sasha Salama to discuss the company's major milestones and catalysts.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).